Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Meloxicam Capsules in Subjects With Osteoarthritis of the Knee or Hip

ClinicalTrials.gov ID: NCT01801735

Public ClinicalTrials.gov record NCT01801735. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 8, 2026, 9:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-Label, Safety Study of Meloxicam SoluMatrix™ Capsules in Subjects With Osteoarthritis of the Knee or Hip

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety of Meloxicam SoluMatrix Capsules for up to 52 weeks in subjects with pain due to osteoarthritis (OA) of the knee or hip

Study identification

NCT ID
NCT01801735
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Iroko Pharmaceuticals, LLC
Industry
Enrollment
600 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2013
Primary completion
May 31, 2014
Completion
Jul 31, 2014
Last update posted
May 11, 2015

2013 – 2014

United States locations

U.S. sites
40
U.S. states
19
U.S. cities
35
Facility City State ZIP Site status
Not listed Birmingham Alabama 35216
Not listed Phoenix Arizona 85053
Not listed Carmichael California 95608
Not listed Pismo Beach California 93449
Not listed Milford Connecticut 06460
Not listed DeLand Florida 32720
Not listed Fleming Island Florida 32003
Not listed Jacksonville Florida 32205
Not listed Jacksonville Florida 32216
Not listed Miami Florida 33143
Not listed Ormond Beach Florida 32174
Not listed Ponte Vedra Florida 32081
Not listed Newton Kansas 67114
Not listed Prairie Village Kansas 66206
Not listed Wichita Kansas 67203
Not listed Crestview Hills Kentucky 41017
Not listed Brockton Massachusetts 02301
Not listed Traverse City Michigan 49684
Not listed Troy Michigan 48098
Not listed Hazelwood Missouri 63042
Not listed St Louis Missouri 63141
Not listed Omaha Nebraska 68134
Not listed Las Vegas Nevada 89144
Not listed Hartsdale New York 10530
Not listed Greensboro North Carolina 27408
Not listed Cincinnati Ohio 45219
Not listed Cincinnati Ohio 45227
Not listed Cincinnati Ohio 45255
Not listed Cincinnati Ohio 45256
Not listed Columbus Ohio 43212
Not listed Kettering Ohio 45429
Not listed Duncansville Pennsylvania 16635
Not listed Anderson South Carolina 29621
Not listed Clinton South Carolina 29325
Not listed Austin Texas 78705
Not listed Plano Texas 75075
Not listed San Antonio Texas 78209
Not listed San Antonio Texas 78229
Not listed Charlottesville Virginia 22911
Not listed Roanoke Virginia 24018

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01801735, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 11, 2015 · Synced Sep 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01801735 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →